Contact Us

DESTINATION NEWS

CStone Announces Abstract Release of CS5001 (ROR1 ADC) First-in-Human Clinical Data on ASCO Website

May 30, 2024

CS5001 is the first known ROR1 antibody-drug conjugate (ADC) to demonstrate clinical anti-tumor activity in both solid tumors and lymphomas,and among the top two globally in clinical development.

HoneyNaps secures a $11.6 million Series B investment, becoming the No. 1 ranked A.I Sleep Technology Company

May 30, 2024

HoneyNaps secures $11.6 million in series B funding,propelling its entry into the American medical market.

URBAN SPORTS AND STREET ARTS MEET IN SINGAPORE AS PART OF A GLOBAL WARM-UP TO THE PARIS 2024 OLYMPIC GAMES

May 30, 2024

The unique event,which is among the first global events created to build excitement for the upcoming Olympic Games,sees French andSingaporeans athletes and artists coming together to revitalise the ic

Transcenta Debuts Encouraging Phase II Data from First-line Triple Combo Trial of Osemitamab (TST001) for G/GEJ Cancer at ASCO 2024

May 30, 2024

Phase II results reveal median PFS of 12.6 months in patients with CLDN18.2 high or medium expression,including in patients with PD-L1 CPS<5.

Nagad becomes successful unicorn startup within 3 years

May 30, 2024

DHAKA,Bangladesh,May 24,2024-- Within just three years of its inception,Nagad,a leading mobile financial service provider based in Bangladesh,has established itself as the most successful startup uni

Geespace Expands Global Reach with LEO Satellite Constellation

May 30, 2024

SHANGHAI,May 24,2024-- SpaceX\'s Starlink recently officially announced their high-speed internet constellation is now connecting more than 3 million people with high-speed internet across nearly 100

1 ... 289 290 291 292 293 294 295 ... 302